medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2012, Número 5

<< Anterior Siguiente >>

Ann Hepatol 2012; 11 (5)


Does the size of the needle influence the number of portal tracts obtained through percutaneous liver biopsy?

Sporea I, Gherhardt D, Popescu A, Sirli R, Cornianu M, Herman D, Bota S

Idioma: Ingles.
Referencias bibliográficas: 21
Paginas: 691-695
Archivo PDF: 85.56 Kb.


RESUMEN

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Friedman LS. Controversies in liver biopsy: who, where, when, how and why? Current Gastroenterology Reports 2004; 6: 30-6.

  2. The British Society of Gastroenterology Guidelines on the use of liver biopsy in clinical practice. Gut 1999; 45 (Suppl. 4): 1-11.

  3. Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis Feb 2004; 24: 89-97.

  4. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003; 39: 239-44

  5. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis. Hepatology 2003; 38: 1449-57.

  6. Beaugrand M. FibroScan instructions for use. Journées Francophones de Pathologie Digestive. Gastroenterol Clin Biol 2006; 30: 513-4.

  7. de Man RA, van Buuren HR, Hop WC. A randomised study on the efficacy and safety of an automated Tru-Cut needle for percutaneous liver biopsy. Neth J Med 2004; 62: 441-5.

  8. Sherman KE, Goodman ZD, Sullivan ST, Faris-Young S; GILF Study Group. Liver biopsy in cirrhotic patients. Am J Gastroenterol 2007; 102: 789-93.

  9. Sporea I, Popescu A, Curescu M, Rogoveanu I, Sandulescu L, Brisc C, Cijevschi Prelipcean C, et al. Is it still justified to consider liver biopsy as the gold standard for the evaluation of chronic hepatopaties? Gut 2010; 59(Suppl. III): A433.

  10. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy: a multiple retrospective study on 68276 biopsies. J Hepatol 1986; 2: 165-73.

  11. Cholongitas E, Senzolo M, Standish R, Marelli L, Quaglia A, Patch D, Dhillon AP, et al. A systematic review of the quality of liver biopsy specimens. Am J Clin Pathol 2006; 125: 710-21.

  12. Röcken C, Meier H, Klauck S, Wolff S, Malfertheiner P, Roessner A. Large-needle biopsy versus thin-needle biopsy in diagnostic pathology of liver diseases. Liver 2001; 21: 391-7.

  13. Petz D, Klauck S, Röhl FW, Malfertheiner P, Roessner A, Röcken C. Feasibility of histological grading and staging of chronic viral hepatitis using specimens obtained by thinneedle biopsy. Virchows Arch 2003; 442: 238-44.

  14. Brunetti E, Silini E, Pistorio A, Cavallero A, Marangio A, Bruno R, Filice C. Coarse vs. fine needle aspiration biopsy for the assessment of diffuse liver disease from hepatitis C virus–related chronic hepatitis. J Hepatol 2004; 40: 501-6.

  15. Poynard T, Halfon P, Castera L, Charlotte F, Le Bail B, Munteanu M, Messous D, et al; FibroPaca Group. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Aliment Pharmacol Ther 2007; 25: 733-9.

  16. Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, Messous D, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004; 50: 1344-55.

  17. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, Colombo M. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic evaluation of liver fibrosis in patients with chronic. Gut 2007; 56; 968-73.

  18. Sporea I, Sirli R, Popescu A, Cornianu M, Manciu C, Focsa M. The quality of the fragment obtained by liver biopsy for staging chronic hepatitis. J Gastrointestin Liver Dis 2007; 16: 263-6.

  19. Sporea I, Popescu A, Sirli R. Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol 2008; 14: 3396-402.

  20. Sporea I, Popescu A, Sirli R. How to improve the quality of the tissue sample obtained by percutaneous liver biopsy. Central European Journal of Medicine 2011; 6: 103-6.

  21. Gazelle GS, Haaga JR, Rowland DY. Effect of needle gauge, level of anticoagulation, and target organ on bleeding associated with aspiration biopsy. Work in progress. Radiology 1992; 183: 509-13.




2020     |     www.medigraphic.com